5th Circ. Upholds Drug Negotiations In Blow To Big Pharma
Medicare's landmark program of drug price negotiations doesn't flout constitutional provisions involving the separation of powers, due process or excessive fines, the Fifth Circuit ruled late Wednesday, delivering a fresh blow...To view the full article, register now.
Already a subscriber? Click here to view full article